[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL324319A1 - 1,6-disubstituted isochromates for fighting against sick headaches - Google Patents

1,6-disubstituted isochromates for fighting against sick headaches

Info

Publication number
PL324319A1
PL324319A1 PL96324319A PL32431996A PL324319A1 PL 324319 A1 PL324319 A1 PL 324319A1 PL 96324319 A PL96324319 A PL 96324319A PL 32431996 A PL32431996 A PL 32431996A PL 324319 A1 PL324319 A1 PL 324319A1
Authority
PL
Poland
Prior art keywords
isochromates
headaches
disubstituted
fighting against
against sick
Prior art date
Application number
PL96324319A
Inventor
Michael D Ennis
Ruth E Tenbrink
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of PL324319A1 publication Critical patent/PL324319A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76Benzo[c]pyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL96324319A 1995-06-30 1996-06-07 1,6-disubstituted isochromates for fighting against sick headaches PL324319A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74195P 1995-06-30 1995-06-30
US1123496P 1996-02-06 1996-02-06

Publications (1)

Publication Number Publication Date
PL324319A1 true PL324319A1 (en) 1998-05-25

Family

ID=26668092

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96324319A PL324319A1 (en) 1995-06-30 1996-06-07 1,6-disubstituted isochromates for fighting against sick headaches

Country Status (12)

Country Link
EP (1) EP0836599A1 (en)
JP (1) JPH11509532A (en)
AU (1) AU6252296A (en)
BR (1) BR9609631A (en)
CA (1) CA2225282A1 (en)
CZ (1) CZ418597A3 (en)
FI (1) FI974640A (en)
MX (1) MX9710260A (en)
NO (1) NO976112L (en)
PL (1) PL324319A1 (en)
SK (1) SK164297A3 (en)
WO (1) WO1997002259A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2370270A (en) * 2000-12-20 2002-06-26 Lilly Co Eli Pharmaceutical compounds
US7335660B2 (en) 2001-12-19 2008-02-26 Eli Lilly And Company Isochroman compounds for treatment of CNS disorders
GB0130339D0 (en) * 2001-12-19 2002-02-06 Lilly Co Eli Isochroman compounds
US7110576B2 (en) 2002-12-30 2006-09-19 Pitney Bowes Inc. System and method for authenticating a mailpiece sender
ATE458727T1 (en) 2004-05-05 2010-03-15 Hoffmann La Roche ARYLSULFONYLBENZODIOXANES SUITABLE FOR MODULATION OF THE 5-HT6 RECEPTOR, THE 5-HT2A RECEPTOR OR BOTH RECEPTORS
EP1831152B1 (en) 2004-12-21 2008-09-24 F. Hoffmann-La Roche AG Tetralin and indane derivatives and uses thereof as 5-ht antagonists
EP1831203A1 (en) 2004-12-21 2007-09-12 F. Hoffmann-Roche AG Chroman derivatives and uses thereof in the treatment of cns disorders
JP2008524274A (en) 2004-12-21 2008-07-10 エフ.ホフマン−ラ ロシュ アーゲー Tetralin and indane derivatives and their use
AU2005318550B2 (en) 2004-12-21 2011-04-07 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
ES2306275T3 (en) 2004-12-21 2008-11-01 F. Hoffmann-La Roche Ag CHROMAN DERIVATIVES AND THEIR USES AS LIGANDS FROM 5-HT RECEIVERS.
WO2007051735A1 (en) 2005-11-03 2007-05-10 F. Hoffmann-La Roche Ag Arylsulfonylchromans as 5-ht6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors
MX2008015511A (en) 2006-06-20 2008-12-18 Hoffmann La Roche Arylsulfonyl naphthalene derivatives and uses thereof.
EP2076489A1 (en) 2006-06-20 2009-07-08 F. Hoffmann-Roche AG Arylsulfonamidyl tetralin derivatives and uses thereof
WO2007147771A2 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
JP2010229128A (en) * 2009-03-05 2010-10-14 Sumitomo Chemical Co Ltd Halogen-substituted terephthalic acid diamide compound, method for producing the same, and method for producing halogen-substituted benzene dimethanol by using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives
CN1046507C (en) * 1993-12-28 1999-11-17 法玛西雅厄普约翰美国公司 Heterocyclic compounds for the treatment of CNS and cardiovascular disorders

Also Published As

Publication number Publication date
NO976112D0 (en) 1997-12-29
WO1997002259A1 (en) 1997-01-23
FI974640A0 (en) 1997-12-30
EP0836599A1 (en) 1998-04-22
CA2225282A1 (en) 1997-01-23
AU6252296A (en) 1997-02-05
JPH11509532A (en) 1999-08-24
MX9710260A (en) 1998-03-29
BR9609631A (en) 1999-03-02
CZ418597A3 (en) 1998-06-17
FI974640A (en) 1997-12-30
SK164297A3 (en) 1998-09-09
NO976112L (en) 1998-03-02

Similar Documents

Publication Publication Date Title
HK1010620A1 (en) Rate controller
GR3033254T3 (en) 1 alpha, 26-dihydroxy-D-homo-vitamin D3
IL134108A0 (en) Substituted 1,2,3,4-tetrahydronaphthalene derivatives
PL324319A1 (en) 1,6-disubstituted isochromates for fighting against sick headaches
ZA97944B (en) N: 1 Transcoder.
AU3229595A (en) Mains signalling systems
IL116338A0 (en) Sprinkler
ZA969625B (en) 25-Hydroxy-16-ene-26, 27-bishomo-cholecalciferols
AU3570895A (en) Mains signalling systems
AU5922894A (en) 2,6-Disubstituted 4-quinolyl-dihydropyridines
ZA965465B (en) 2,4,5-Trisubstituted phenylketoenois
IL119744A0 (en) Use of 8,9-dehydroestrone
GB9515173D0 (en) The fighting flex
GB9515061D0 (en) "Brake"
AU2137095A (en) Heterocyclyl-1,3,4-thiadiazolyloxyacetamides
HU9503125D0 (en) Safety shelves especially for cassets
EP0674138A3 (en) Under ceiling.
ZA968953B (en) 24-homo-26,27-hexafluoro-cholecalciferols
GB9425969D0 (en) Multi-path swivel
AUPN495395A0 (en) The intensi'fire'
ZA97160B (en) Sprinkler.
AUPM443394A0 (en) Piratela, piracy prevention system
GB9413652D0 (en) Sprinkler system
GB9422385D0 (en) Sprinkler system
GB9420105D0 (en) Sprinkler system